The FDA removes its clinical hold on Arbutus’s experimental AB-101 hepatitis B treatment. No new trial has been announced yet.
#FDA #USA #Biotech
Disclaimer: This is NOT a financial advice
The FDA removes its clinical hold on Arbutus’s experimental AB-101 hepatitis B treatment. No new trial has been announced yet. #FDA #USA #Biotech Disclaimer: This is NOT a financial advice
0 views
Published on 12/11/2026 02:49
0:55
The FDA removes its clinical hold on Arbutus’s experimental AB-101 hepatitis B treatment. No new trial has been announced yet.
#FDA #USA #Biotech
Disclaimer: This is NOT a financial advice
biotechstockdaily.com/fda-clinical...